-
Je něco špatně v tomto záznamu ?
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications
E. Sticova, M. Jirsa, J. Pawłowska,
Jazyk angličtina Země Egypt
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2005 do Před 1 rokem
PubMed Central
od 2014
Europe PubMed Central
od 2014
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 1987-01-01
Open Access Digital Library
od 1987-01-01
Open Access Digital Library
od 2014-01-01
Medline Complete (EBSCOhost)
od 2014-01-01
Health & Medicine (ProQuest)
od 2013-01-01
Wiley-Blackwell Open Access Titles
od 1987
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
30148122
DOI
10.1155/2018/2313675
Knihovny.cz E-zdroje
- MeSH
- ABC transportér, podrodina B, člen 11 genetika MeSH
- adenosintrifosfatasy genetika MeSH
- intrahepatální cholestáza genetika metabolismus MeSH
- komplikace těhotenství genetika MeSH
- lidé MeSH
- P-glykoproteiny nedostatek genetika MeSH
- proteiny přenášející anionty metabolismus MeSH
- receptory cytoplazmatické a nukleární genetika metabolismus MeSH
- žlučové kyseliny a soli biosyntéza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Cholestasis is characterised by impaired bile secretion and accumulation of bile salts in the organism. Hereditary cholestasis is a heterogeneous group of rare autosomal recessive liver disorders, which are characterised by intrahepatic cholestasis, pruritus, and jaundice and caused by defects in genes related to the secretion and transport of bile salts and lipids. Phenotypic manifestation is highly variable, ranging from progressive familial intrahepatic cholestasis (PFIC)-with onset in early infancy and progression to end-stage liver disease-to a milder intermittent mostly nonprogressive form known as benign recurrent intrahepatic cholestasis (BRIC). Cases have been reported of initially benign episodic cholestasis that subsequently transitions to a persistent progressive form of the disease. Therefore, BRIC and PFIC seem to represent two extremes of a continuous spectrum of phenotypes that comprise one disease. Thus far, five representatives of PFIC (named PFIC1-5) caused by pathogenic mutations present in both alleles of ATP8B1, ABCB11, ABCB4, TJP2, and NR1H4 have been described. In addition to familial intrahepatic cholestasis, partial defects in ATP8B1, ABCB11, and ABCB4 predispose patients to drug-induced cholestasis and intrahepatic cholestasis in pregnancy. This review summarises the current knowledge of the clinical manifestations, genetics, and molecular mechanisms of these diseases and briefly outlines the therapeutic options, both conservative and invasive, with an outlook for future personalised therapeutic strategies.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012433
- 003
- CZ-PrNML
- 005
- 20190425114836.0
- 007
- ta
- 008
- 190405s2018 ua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2018/2313675 $2 doi
- 035 __
- $a (PubMed)30148122
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ua
- 100 1_
- $a Sticova, Eva $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague 4, 140 21, Czech Republic. Department of Pathology, Third Faculty of Medicine, Charles University, Prague 10, 100 00, Czech Republic.
- 245 10
- $a New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications / $c E. Sticova, M. Jirsa, J. Pawłowska,
- 520 9_
- $a Cholestasis is characterised by impaired bile secretion and accumulation of bile salts in the organism. Hereditary cholestasis is a heterogeneous group of rare autosomal recessive liver disorders, which are characterised by intrahepatic cholestasis, pruritus, and jaundice and caused by defects in genes related to the secretion and transport of bile salts and lipids. Phenotypic manifestation is highly variable, ranging from progressive familial intrahepatic cholestasis (PFIC)-with onset in early infancy and progression to end-stage liver disease-to a milder intermittent mostly nonprogressive form known as benign recurrent intrahepatic cholestasis (BRIC). Cases have been reported of initially benign episodic cholestasis that subsequently transitions to a persistent progressive form of the disease. Therefore, BRIC and PFIC seem to represent two extremes of a continuous spectrum of phenotypes that comprise one disease. Thus far, five representatives of PFIC (named PFIC1-5) caused by pathogenic mutations present in both alleles of ATP8B1, ABCB11, ABCB4, TJP2, and NR1H4 have been described. In addition to familial intrahepatic cholestasis, partial defects in ATP8B1, ABCB11, and ABCB4 predispose patients to drug-induced cholestasis and intrahepatic cholestasis in pregnancy. This review summarises the current knowledge of the clinical manifestations, genetics, and molecular mechanisms of these diseases and briefly outlines the therapeutic options, both conservative and invasive, with an outlook for future personalised therapeutic strategies.
- 650 _2
- $a P-glykoproteiny $x nedostatek $x genetika $7 D018435
- 650 _2
- $a ABC transportér, podrodina B, člen 11 $x genetika $7 D000074020
- 650 _2
- $a adenosintrifosfatasy $x genetika $7 D000251
- 650 _2
- $a proteiny přenášející anionty $x metabolismus $7 D027321
- 650 _2
- $a žlučové kyseliny a soli $x biosyntéza $7 D001647
- 650 _2
- $a intrahepatální cholestáza $x genetika $x metabolismus $7 D002780
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a komplikace těhotenství $x genetika $7 D011248
- 650 _2
- $a receptory cytoplazmatické a nukleární $x genetika $x metabolismus $7 D018160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Jirsa, Milan $u Laboratory of Experimental Hepatology, Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague 4, 140 21, Czech Republic.
- 700 1_
- $a Pawłowska, Joanna $u Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children's Memorial Health Institute (CMHI), Warsaw 04-730, Poland.
- 773 0_
- $w MED00198695 $t Canadian journal of gastroenterology & hepatology $x 2291-2797 $g Roč. 2018, č. - (2018), s. 2313675
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30148122 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190425114911 $b ABA008
- 999 __
- $a ok $b bmc $g 1391743 $s 1050738
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 2018 $c - $d 2313675 $e 20180726 $i 2291-2797 $m Canadian journal of gastroenterology & hepatology $n Can J Gastroenterol Hepatol $x MED00198695
- LZP __
- $a Pubmed-20190405